SARS Coronavirus-2 variant tracing within the first Coronavirus Disease 19 clusters in northern Germany.


Journal

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
ISSN: 1469-0691
Titre abrégé: Clin Microbiol Infect
Pays: England
ID NLM: 9516420

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 06 06 2020
revised: 18 09 2020
accepted: 19 09 2020
pubmed: 3 10 2020
medline: 1 1 2021
entrez: 2 10 2020
Statut: ppublish

Résumé

Investigation whether in depth characterization of virus variant patterns can be used for epidemiological analysis of the first severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection clusters in Hamburg, Germany. Metagenomic RNA-sequencing and amplicon-sequencing and subsequent variant calling in 25 respiratory samples from SARS-CoV-2 infected patients involved in the earliest infection clusters in Hamburg. Amplikon sequencing and cluster analyses of these SARS-CoV-2 sequences allowed the identification of the first infection cluster and five non-related infection clusters occurring at the beginning of the viral entry of SARS-CoV-2 in the Hamburg metropolitan region. Viral genomics together with epidemiological analyses revealed that the index patient acquired the infection in northern Italy and transmitted it to two out of 134 contacts. Single nucleotide polymorphisms clearly distinguished the virus variants of the index and other clusters and allowed us to track in which sequences worldwide these mutations were first described. Minor variant analyses identified the transmission of intra-host variants in the index cluster and household clusters. SARS-CoV-2 variant tracing allows the identification of infection clusters and the follow up of infection chains occurring in the population. Furthermore, the follow up of minor viral variants in infection clusters can provide further resolution on transmission events indistinguishable at a consensus sequence level.

Identifiants

pubmed: 33007476
pii: S1198-743X(20)30587-5
doi: 10.1016/j.cmi.2020.09.034
pmc: PMC7524521
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

130.e5-130.e8

Informations de copyright

Copyright © 2020 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Références

N Engl J Med. 2020 Jun 11;382(24):2302-2315
pubmed: 32289214
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Science. 2020 Jul 31;369(6503):582-587
pubmed: 32513865
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Science. 2020 Sep 4;369(6508):1255-1260
pubmed: 32703910
Microbiol Resour Announc. 2020 Jun 4;9(23):
pubmed: 32499358
Euro Surveill. 2020 Mar;25(9):
pubmed: 32156329
Genomics. 2020 Sep;112(5):3588-3596
pubmed: 32353474
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Clin Infect Dis. 2020 Jul 28;71(15):713-720
pubmed: 32129843

Auteurs

Susanne Pfefferle (S)

Institute for Medical Microbiology, Virology and Hygiene, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Thomas Günther (T)

Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Virus Genomics, Hamburg, Germany.

Robin Kobbe (R)

I. Medical Clinic and Polyclinic, Section Infectious Diseases, University Medical Centre Eppendorf, Hamburg, Germany.

Manja Czech-Sioli (M)

Institute for Medical Microbiology, Virology and Hygiene, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Dominic Nörz (D)

Institute for Medical Microbiology, Virology and Hygiene, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

René Santer (R)

Department of Pediatrics, University Medical Center Eppendorf, Hamburg, Germany.

Jun Oh (J)

Department of Pediatrics, University Medical Center Eppendorf, Hamburg, Germany.

Stefan Kluge (S)

Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Lisa Oestereich (L)

Bernhard Nocht Institute, Leibniz Institute for Tropical Medicine, Hamburg, Germany.

Kersten Peldschus (K)

Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Daniela Indenbirken (D)

Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Virus Genomics, Hamburg, Germany.

Jiabin Huang (J)

Institute for Medical Microbiology, Virology and Hygiene, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Adam Grundhoff (A)

Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Virus Genomics, Hamburg, Germany.

Martin Aepfelbacher (M)

Institute for Medical Microbiology, Virology and Hygiene, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany. Electronic address: m.aepfelbacher@uke.de.

Johannes K Knobloch (JK)

Institute for Medical Microbiology, Virology and Hygiene, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany. Electronic address: j.knobloch@uke.de.

Marc Lütgehetmann (M)

Institute for Medical Microbiology, Virology and Hygiene, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany. Electronic address: mluetgehetmann@uke.de.

Nicole Fischer (N)

Institute for Medical Microbiology, Virology and Hygiene, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany. Electronic address: nfischer@uke.de.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH